Global logistics leader DHL Group has announced a major investment of €500 million (approximately US$575 million) over the next five years to scale up its healthcare and logistics infrastructure across Africa and the Middle East. The move signals DHL’s intensified focus on strengthening supply chains for critical medical shipments while positioning the region as a central player in global commerce.
The ambitious expansion plan—part of DHL’s broader €2 billion global healthcare investment strategy—will target key markets such as South Africa, Egypt, Kenya, the United Arab Emirates, and Saudi Arabia. The initiative is set to enhance the handling of essential and highly sensitive medical materials, including vaccines, stem cells, insulin therapies, and cryogenically stored pharmaceuticals.
DHL’s regional investment will go toward boosting warehousing capacity, upgrading packaging systems, and enhancing cold-chain logistics to ensure the safe delivery, integrity, and traceability of medical products. These developments come in response to growing demand for reliable, fast, and compliant healthcare logistics solutions in both emerging and established markets.
“This strategic investment underscores our commitment to building resilient healthcare supply chains in regions that are critical to global health and trade,” the company stated. “By strengthening infrastructure and logistics capabilities, we aim to enable better access to life-saving therapies while supporting economic growth.”
In addition to healthcare, the investment will reinforce DHL’s general logistics operations in the Middle East—particularly in Saudi Arabia and the UAE—by expanding network coverage, upgrading service infrastructure, and enhancing last-mile delivery systems. All four DHL divisions—DHL Express, DHL Global Forwarding, DHL Supply Chain, and DHL eCommerce—will benefit from the regional upgrade.
The Middle East is rapidly emerging as a strategic trade corridor linking Asia, Europe, and North America. It also serves as a vital access point to African markets. DHL’s investment reflects its long-term vision to support this region’s transformation into a key hub for international logistics, while simultaneously nurturing local enterprise and supporting cross-border commerce.
By aligning its operations with the evolving needs of healthcare providers, pharmaceutical companies, and regional economies, DHL Group is positioning itself at the forefront of supply chain innovation—fostering access, connectivity, and reliability where it matters most.
